Entomed Overview

  • Founded
  • 1908

Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 1

Employees

  • Latest Deal Type
  • M&A

Entomed General Information

Description

Provider of audiometers. The company's audiometers provides therapeutic services for ENT in Sweden.

Contact Information

Website
www.entomed.se
Formerly Known As
Entomed Production
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Other Healthcare Services
Other Industries
Other Healthcare Technology Systems
Acquirer
Auditdata
Primary Office
  • Ridspögatan 5
  • 213 77 Malmo
  • Sweden
+46 040-21 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Entomed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Jan-2015 000.00 Completed Generating Revenue
1. Early Stage VC (Series B) 18-Dec-2000 000.00 000.00 Completed Startup
To view Entomed’s complete valuation and funding history, request access »

Entomed Patents

  • 30

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Entomed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2012671-A1 A method and a device for hearing-related examination Inactive 19-Apr-2006 000000000
US-20110034827-A1 Method and a device for hearing-related examination Inactive 19-Apr-2006 00000000
FR-2860793-A1 New norcantharidin derivatives e.g. used for treating cancer, neurodegenerative diseases, restenosis, diabetes, asthma and bacterial and fungal infections Inactive 14-Oct-2003 0000000000 0
FR-2850656-A1 New isolated antifungal peptide from acrocinus longimanus, useful in human or veterinary medicine and plant protection, also related nucleic acid for preparing fungus-resistant transgenic plants Inactive 31-Jan-2003 000000000000
AU-2003276325-A1 Antimicrobial peptides, polypeptides comprising same, genes coding for said peptides, vectors, transformed organisms and compositions containing same Inactive 13-Aug-2002 C07K14/43563
To view Entomed’s complete patent history, request access »

Entomed Board Members (2)

Name Representing Role Since
Carsten Waern Entomed Board Member 000 0000
You’re viewing 1 of 2 board members. Get the full list »

Entomed Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Entomed Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Apax Partners PE/Buyout Minority 000 0000 000000 0
Auriga Partners (Paris) Venture Capital Minority 000 0000 000000 0
Sofinov Venture Capital Minority 000 0000 000000 0
To view Entomed’s complete investors history, request access »

Ready to get started?

Request a free trial